Scientific requirements for the environmental risk assessment of gene-therapy medicinal products

  • Email
  • Help
Current version

Adopted guideline

Reference numberCHMP/GTWP/125491/06
Effective from01/11/2008
KeywordsEnvironmental risk, genetically modified organism (GMO), gene therapy, medicinal product, deliberate release
DescriptionThis dcument provides guidance on the environmental risk assessment of GMO-containing gene therapy medicinal products, as required for marketing authorisation under the centralised procedure. It aims to facilitate the application of the methodology laid down in the Directive 2001/18/EC on the deliberate release into the environment of genetically modified organisms.

Document history

First version 

Current version

Adopted guideline

Overview of comments

Draft guideline

Concept paper

In operation: 01/11/2008

Published: 30/05/2008

Published: 08/02/2007

Published: 17/11/2005

Related content

How helpful is this page?

Average rating:

 Based on 30 ratings

Add your rating:

See all ratings
6 ratings
6 ratings
6 ratings
6 ratings
6 ratings

Tell us more